Clinical Trial Update: Prenatal Pelvic Floor Prevention (3PN) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial on prenatal pelvic floor prevention (3PN) has completed, evaluating urinary incontinence, anal incontinence, and pelvic organ prolapse.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Incontinence
• Pelvic Organ Prolapse
• Urinary Incontinence

Snippet

Sponsor: Centre Hospitalier Universitaire de la Réunion | Conditions: Urinary Incontinence, Anal Incontinence | Phase 3 | Status: COMPLETED